Bodypharm Cagrisema 12 mg pen

Body Pharm Cagrisema 12mg Pen?

The BP Cagrisema 12mg Pen contains 6 mg of Semaglutide and 6mg of Cagrilintide per pen. This pen dispenses 0.25mg , 0.5 mg, 0.75mg ,1 mg and 2 mg of both api’s per injection. It is a medicine for weight loss and weight maintenance that contains the active substance semagltide and Cagrilintide. Semaglutide is similar to a natural hormone called glucagon-like peptide-1 (GLP-1) that is released from the intestine after a meal.

What does it do?

Semaglutide works by acting on receptors in the brain that control your appetite, causing you to feel fuller and less hungry and experience less craving for food. This will help you eat less food and reduce your body weight. Cagrilintide is a long-acting amylin analogue that is currently being investigated for its potential use in the treatment of obesity and related metabolic conditions. It mimics the effects of the natural hormone amylin.

When both Semaglutide and Cagrilinitide are used together the overall efficacy is enhanced greatly. The most apparent result will be enhanced weight loss much greater than that of Semaglutide on its own.

This product contains both Semaglutide and Cagrlintide. When selecting a dosage on the pen unit for example 0.25mg. This will dispense 0.25mg of Semaglutide and 0.25mg of Cagrilintide at the same time.

What Cagrisema 12 mg is used for:

Cagrisema 12 mg is used for weight loss and weight maintenance in addition to diet and physical activity in adults, who have:

• a BMI of 30 kg/m² or greater (with obesity) or
• a BMI of 27 kg/m² and less than 30 kg/m² (overweight) and weight-related health problems.

The Body Pharm BP Cagrisema 12mg Pen Benefits:

• Weight loss and weight maintenance: contains the active substance Semaglutide and Cagrilintide.
• Semaglutide promotes weight loss: increases satiety, reducing food intake and aiding in weight reduction.
• Enhanced weight loss with Semaglutide & Gagrilinitide: Cagrilintide is a long-acting amylin analogue (treatment of obesity) and related metabolic conditions. It mimics the effects of the natural hormone amylin. When both Semaglutide and Cagrilinitide are used together the overall efficacy is enhanced greatly.